Kayne Anderson Rudnick Investment Management LLC Insmed Inc Transaction History

Kayne Anderson Rudnick Investment Management LLC

$42 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$17.07 - $25.71 $1,963 - $2,956	-115 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $2,348 - $3,234	115 New	115 $3,000

Others Institutions Holding INSM

# of Institutions

502

Shares Held

188M

Call Options Held

3.21M

Put Options Held

2.72M

Vanguard Group Inc Valley Forge, PA

18.2M
Shares

$1.27 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$992 Million
0.02% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

13M
Shares

$901 Million
84.75% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.7M
Shares

$883 Million
0.1% of portfolio
Capital International Investors Los Angeles, CA

7.12M
Shares

$495 Million
0.1% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.42B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account